June 24, 2025
Findings of the BEATcc trial suggest PD-L1 status is not a reliable biomarker for guiding immunotherapy selection in patients with recurrent or metastatic cervical cancer, potentially […]
June 24, 2025
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved serplulimab (Hetronifly, Henlius) to treat adults with extensive-stage small cell lung cancer (ES-SCLC). Serplulimab is the […]
June 24, 2025
TOPLINE: A recent study found that 3 months of resistance training did not worsen lymphedema in breast cancer survivors and instead significantly improved fluid balance and […]
June 24, 2025
LUGANO, Switzerland — Patients with diffuse large B-cell lymphoma (DLBCL) in a genetic subgroup associated with worse outcomes show significantly greater responses to treatment with the […]
June 23, 2025
The FDA has granted accelerated approval to datopotamab deruxtecan-dlnk (Datroway, Daiichi Sankyo) for certain patients with locally-advanced or metastatic epidermal growth factor receptor (EGFR)-mutated non-small cell […]
June 23, 2025
TOPLINE: Continuing anti-vascular endothelial growth factor (VEGF) therapy plus chemotherapy in the second-line setting led to a small but nonsignificant increase in overall survival in patients […]
June 23, 2025
TOPLINE: Robotic-assisted thoracic surgery (RATS) was safe in patients aged 80 years or older with lung cancer and demonstrated comparable postoperative outcomes to younger patients, a […]
June 23, 2025
GLPG5101, a second-generation anti-CD19/4-1BB CAR T-cell therapy, shows high complete response rates in the treatment of high-risk indolent relapsed/refractory (r/r) non-Hodgkin lymphoma, with a notably shortened […]
June 20, 2025
Cancer patients should seek medical advice before using weight-loss injections, a leading UK charity has said. Macmillan Cancer Support urged patients not to view these drugs […]